In rodent studies, GLP-1 receptors are present in key areas of the central nervous system that regulate appetite
Moreover, liposomal formulations have been integrated with ultraviolet (UV) light therapy, demonstrating significant depigmentation effects in clinical studies [208]
Furthermore, research into the HPA Axis is evaluating how the reduction in glucose-induced oxidative stress with sitagliptin helps preserve the integrity of the vascular endothelium and reduces chronic cortisol production in metabolic syndrome patients
It targets three key receptors simultaneously glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
medicine.com/drug/semaglutide/hcp Storgaard H, Cold F, Gluud LL, Vilsbll T, Knop FK